HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating perivascular progenitors: a target of PDGFR inhibition.

Abstract
Cancer blood vessels consist of two interacting types of cells: inner lining endothelial cells (ECs) and surrounding perivascular cells (pericytes, vascular smooth muscle cells or mural cells). PDGFRbeta(CD140b)+ progenitor perivascular cells (PPC) can differentiate into pericytes and regulate vessel stability and vascular survival in tumors. Similarly to what we have done with circulating ECs and progenitors, we developed a flow cytometry procedure for the enumeration of circulating PPCs and the study of their viability in murine models of cancer and in cancer patients. DNA+CD45-CD31-CD140b+ cells were enumerated by six-colour flow cytometry, their morphology was studied by electron microscopy, PPC specificity confirmed by reverse trascription-PCR (RT-PCR) expression of CD140b mRNA, and viability assessed by Syto16 and 7AAD. In preclinical marrow transplantation studies, 9 ± 4% of circulating PPCs were derived from the marrow donor. PPCs were increased in cancer-bearing mice and in patients affected by some types of cancer. At variance with the kinetic of circulating endothelial progenitors, high-dose cyclophosphamide reduced the number of viable PPCs. The administration of sunitinib, a drug known to inhibit PDGFR, was associated in murine models and in cancer patients with an increase of apoptotic/necrotic circulating PPC, suggesting a direct targeting of these cells. PPC enumeration might be studied as a tool for the definition of the optimal biologic dose of anti-PDGFR drugs and investigated clinically as a possible predictive/prognostic tool in patients receiving anti-PDGFR drugs.
AuthorsPatrizia Mancuso, Ines Martin-Padura, Angelica Calleri, Paola Marighetti, Jessica Quarna, Cristina Rabascio, Paola Braidotti, Francesco Bertolini
JournalInternational journal of cancer (Int J Cancer) Vol. 129 Issue 6 Pg. 1344-50 (Sep 15 2011) ISSN: 1097-0215 [Electronic] United States
PMID21128230 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 UICC.
Chemical References
  • Angiogenesis Inhibitors
  • Indoles
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Pyrroles
  • Receptor, Platelet-Derived Growth Factor beta
  • Sunitinib
Topics
  • Angiogenesis Inhibitors
  • Animals
  • Bone Marrow Cells (cytology)
  • Cell Count
  • Cell Differentiation
  • Cell Survival (drug effects)
  • Humans
  • Indoles (pharmacology)
  • Mice
  • Neoplasms (blood)
  • Pericytes (cytology, metabolism, physiology)
  • Platelet Endothelial Cell Adhesion Molecule-1 (metabolism)
  • Pyrroles (pharmacology)
  • Receptor, Platelet-Derived Growth Factor beta (antagonists & inhibitors, metabolism)
  • Stem Cells (cytology, metabolism, physiology)
  • Sunitinib

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: